[Nephrotoxicity of anti-infective agents].
Sakamoto
Mitsuo
M
Department of Internal Medicine, Jikei University School of Medicine.
Shiba
Kohya
K
D000617:Aminoglycosides; D000666:Amphotericin B / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015780:Carbapenems / Q000009:adverse effects; D002511:Cephalosporins / Q000009:adverse effects; D004334:Drug Administration Schedule; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced*; D010406:Penicillins / Q000009:adverse effects; D010455:Peptides
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D015780:Carbapenems; D002511:Cephalosporins; D010406:Penicillins; D010455:Peptides; D000666:Amphotericin B